N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide

C54H71Cl4N5O4S — CID 54272503

IUPACN-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide
SMILESCCCCCCCCCCCCCC(=O)Nc1ccc(Cl)c(Nc2[nH]n(-c3c(Cl)cc(Cl)cc3Cl)c(=O)c2SC2C=CC=CC2NC(=O)C(CC)Oc2ccc(C(C)CC)cc2C(C)(C)CC)c1
InChIInChI=1S/C54H71Cl4N5O4S/c1-8-12-13-14-15-16-17-18-19-20-21-26-48(64)59-38-28-29-40(56)44(34-38)60-51-50(53(66)63(62-51)49-41(57)32-37(55)33-42(49)58)68-47-25-23-22-24-43(47)61-52(65)45(10-3)67-46-30-27-36(35(5)9-2)31-39(46)54(6,7)11-4/h22-25,27-35,43,45,47,60,62H,8-21,26H2,1-7H3,(H,59,64)(H,61,65)
InChIKeyRLDHLDHJQAPXKC-UHFFFAOYSA-N
MW1028.07 g/mol
LogP16.29
Rot. Bonds27

About N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide

N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide (PubChem CID 54272503) has the molecular formula C54H71Cl4N5O4S and a molecular weight of 1028.07 g/mol. Its IUPAC name is N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide.

Molecular Properties

Compound NameN-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide
PubChem CID54272503
Molecular FormulaC54H71Cl4N5O4S
Molecular Weight1028.07 g/mol
Exact Mass1025.40
IUPAC NameN-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide
SMILESCCCCCCCCCCCCCC(=O)Nc1ccc(Cl)c(Nc2[nH]n(-c3c(Cl)cc(Cl)cc3Cl)c(=O)c2SC2C=CC=CC2NC(=O)C(CC)Oc2ccc(C(C)CC)cc2C(C)(C)CC)c1
InChIInChI=1S/C54H71Cl4N5O4S/c1-8-12-13-14-15-16-17-18-19-20-21-26-48(64)59-38-28-29-40(56)44(34-38)60-51-50(53(66)63(62-51)49-41(57)32-37(55)33-42(49)58)68-47-25-23-22-24-43(47)61-52(65)45(10-3)67-46-30-27-36(35(5)9-2)31-39(46)54(6,7)11-4/h22-25,27-35,43,45,47,60,62H,8-21,26H2,1-7H3,(H,59,64)(H,61,65)
InChIKeyRLDHLDHJQAPXKC-UHFFFAOYSA-N
XLogP16.29
TPSA117.25 Ų
H-Bond Donors4
H-Bond Acceptors7
Rotatable Bonds27
Heavy Atoms68
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001028.07
LogP ≤ 516.29
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide?
The IUPAC name of N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide (CID 54272503) is N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide.
What is the SMILES notation for N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide?
The canonical SMILES for N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide is CCCCCCCCCCCCCC(=O)Nc1ccc(Cl)c(Nc2[nH]n(-c3c(Cl)cc(Cl)cc3Cl)c(=O)c2SC2C=CC=CC2NC(=O)C(CC)Oc2ccc(C(C)CC)cc2C(C)(C)CC)c1.
What is the InChIKey of N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide?
The InChIKey is RLDHLDHJQAPXKC-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H71Cl4N5O4S/c1-8-12-13-14-15-16-17-18-19-20-21-26-48(64)59-38-28-29-40(56)44(34-38)60-51-50(53(66)63(62-51)49-41(57)32-37(55)33-42(49)58)68-47-25-23-22-24-43(47)61-52(65)45(10-3)67-46-30-27-36(35(5)9-2)31-39(46)54(6,7)11-4/h22-25,27-35,43,45,47,60,62H,8-21,26H2,1-7H3,(H,59,64)(H,61,65).
What are the key properties of N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide?
N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide has a molecular weight of 1028.07 g/mol, XLogP of 16.29, 27 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[4-[6-[2-[4-butan-2-yl-2-(2-methylbutan-2-yl)phenoxy]butanoylamino]cyclohexa-2,4-dien-1-yl]sulfanyl-3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]amino]-4-chlorophenyl]tetradecanamide is sourced from PubChem (CID 54272503), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).